James N. Thomas, Ph.D.

James N. Thomas, Ph.D.

Executive Vice President, Global Head of Biotherapeutics and President U.S. Operations

Jim is leveraging his extensive experience in biotechnology and scientific leadership to help create global patient access to vital medicines through technological innovation.

In his current role at Just-Evotec Biologics, Jim is helping to build biologics capability into the broader offering and capabilities of Evotec SE.  Jim served as CEO and founding partner of Just Biotherapeutics. Prior to Just, Jim served as vice president of Process and Product Development within the Translational Sciences R&D organization at Amgen. In this role, he led the development and application of all process, analytical and formulation technologies used to manufacture both clinical and commercial large molecule products.  Jim was first exposed to biotechnology as a postdoctoral fellow at MIT almost 35 years ago, then worked as a scientist and leader at Genentech, Immunex and Amgen. Over the course of his career, he has contributed to the advancement of many important therapeutics including Activase®, Vectibix®, Enbrel®, Prolia®/Xgeva® and Repatha™. Jim has built teams, departments and functions passionate about creating and using innovative technologies to deliver to the needs of patients, and he and his team at Just are continuing this important mission.

>> back to Leadership